THIRD-PARTY GMP INSPECTIONS OF FIRMS WITH GOOD COMPLIANCE RECORDS UNDER CONSIDERATION; PhRMA SUGGESTS "PRIORITY DESIGNATION SYSTEM" FOR REPORTS
Executive Summary
Third-party GMP inspections of firms with a good compliance track record are under consideration by FDA management, Deputy Associate Commissioner for Regulatory Affairs Gary Dykstra told the annual meeting of the Food & Drug Law Institute in Washington, D.C. Dec. 13.